Entering text into the input field will update the search result below

Agile gains as H.C. Wainwright sees 630% upside potential

Jul. 11, 2022 10:17 AM ETAgile Therapeutics, Inc. (AGRX)EVFMBy: Dulan Lokuwithana, SA News Editor7 Comments

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

  • Agile Therapeutics (NASDAQ:AGRX) rose sharply in the early trading on Monday after H.C. Wainwright doubled the price target on the women's healthcare company to a Street high of $5.00, citing its prospects following the recent Supreme

Recommended For You

Comments (7)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

I did not realize there was a garbage stock in existence that was not already in my portfolio.
Bee202 profile picture
Massive POS … nothing will change until Leadership and/or BOD change!
Dobbs99 profile picture
@Bee202 Unfortunately you are spot on. The CEO and senior management should have been canned a year ago.
I_like_preferreds profile picture
AGRX management disagree. They are dumping shares at 90 cents plus warrants.
Pump and dump on a $28 million market cap stock?
Lost 73.4% of stock price since June 22.
H.C. Wainwright has no credibility.
@dinoperson I ditto the opinion
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.